沃达利单抗
Anti-Human PD-1xCTLA-4 Bispecific Antibody(Vudalimab;XmAb-20717,cytotoxic T-lymphocyte-associated protein 4, CD152;programmed cell death 1, PD1, PD-1, CD279)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Anti-Human PD-1xCTLA-4 Bispecific Antibody(Vudalimab;XmAb-20717,cytotoxic T-lymphocyte-associated protein 4, CD152;programmed cell death 1, PD1, PD-1, CD279)
CAS2329669-72-7
Storage condition Avoid repeated freeze-thaw. -80°C for one-year storage.
Security information
Product details

Vudalimab is a fully humanized bispecific antibody that potently inhibits both PD-1 and CTLA-4, key immune checkpoint receptors. It is designed to selectively activate tumor-targeting T cells, enhancing the immune response against cancer.

Related
Sorry, no related items
History
Navitoclax (ABT-263)
Anti-Human PD-1xCTLA-4 Bispecific Antibody(Vudalimab;XmAb-20717,cytotoxic T-lymphocyte-associated protein 4, CD152;programmed cell death 1, PD1, PD-1, CD279)
Dusigitumab